|View printer-friendly version|
|October 31, 2005 11:51 a.m.|
|Teva Announces Approval of Glipizide and Metformin HCL Tablets|
Jerusalem, Israel, October 31, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Glipizide and Metformin Hydrochloride Tablets, 2.5 mg/250 mg, 2.5 mg/500 mg, and 5 mg/500 mg. Shipment of this product will begin immediately.